Nifty Pharma Share Price

Nifty Pharma share price is ₹22,501 As on 23 December, 2024 | 03:25

The P/E ratio of Nifty Pharma is 35.54 As on 23 December, 2024 | 03:25

The PB ratio of Nifty Pharma is 5.48 As on 23 December, 2024 | 03:25

Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization. 
 

Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing (Index Rebalancing: The index is recalibrated every two years), and no separate stock should have a weightage greater than 33%.

The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd. and Sun Pharmaceuticals Ltd.
 

Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
 

Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
 

Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
 

There are several uses of Nifty Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.